Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men.

PubWeight™: 2.43‹?› | Rank: Top 2%

🔗 View Article (PMID 11502778)

Published in J Clin Endocrinol Metab on August 01, 2001

Authors

S Khosla1, L J Melton, E J Atkinson, W M O'Fallon

Author Affiliations

1: Endocrine Research Unit, Division of Endocrinology, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA. khosla.sundeep@mayo.edu

Articles citing this

(truncated to the top 100)

Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest (2005) 5.19

Endocrine regulation of male fertility by the skeleton. Cell (2011) 3.20

Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment. J Bone Miner Res (2005) 3.11

A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men. J Bone Miner Res (2008) 2.76

Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol (2013) 2.47

Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am J Hum Genet (2004) 1.97

NCCN Task Force Report: Bone Health in Cancer Care. J Natl Compr Canc Netw (2009) 1.97

The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed? J Bone Miner Res (2011) 1.95

Osteoporosis in men. Endocr Rev (2008) 1.80

Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density. Osteoporos Int (2008) 1.73

The effects of serum testosterone, estradiol, and sex hormone binding globulin levels on fracture risk in older men. J Clin Endocrinol Metab (2009) 1.52

Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int (2011) 1.33

Emerging therapies to prevent skeletal morbidity in men with prostate cancer. J Clin Oncol (2011) 1.31

Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study. J Urol (2007) 1.30

Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancer. J Urol (2011) 1.27

Estrogens as regulators of bone health in men. Nat Rev Endocrinol (2009) 1.26

Sex steroid actions in male bone. Endocr Rev (2014) 1.26

Bone fragility in men--where are we? Osteoporos Int (2006) 1.19

Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy. Int J Endocrinol (2012) 1.18

Relationship of volumetric bone density and structural parameters at different skeletal sites to sex steroid levels in women. J Clin Endocrinol Metab (2005) 1.17

Update in male osteoporosis. J Clin Endocrinol Metab (2010) 1.15

Pathogenesis of age-related bone loss in humans. J Gerontol A Biol Sci Med Sci (2012) 1.12

Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men. J Clin Endocrinol Metab (2008) 1.11

Life history context of reproductive aging in a wild primate model. Ann N Y Acad Sci (2010) 1.11

Physiology of bone loss. Radiol Clin North Am (2010) 1.09

Sex steroid hormones in older men: longitudinal associations with 4.5-year change in hip bone mineral density--the osteoporotic fractures in men study. J Clin Endocrinol Metab (2010) 1.04

The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumors. J Natl Compr Canc Netw (2009) 1.03

Aging and bone loss: new insights for the clinician. Ther Adv Musculoskelet Dis (2012) 1.02

Estrogen and bone: insights from estrogen-resistant, aromatase-deficient, and normal men. Bone (2008) 1.01

Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? Endocr Rev (2012) 1.01

Relationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of men. Clin Endocrinol (Oxf) (2008) 1.00

Mitochondrial peptidase IMMP2L mutation causes early onset of age-associated disorders and impairs adult stem cell self-renewal. Aging Cell (2011) 1.00

Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Osteoporos Int (2010) 0.99

Aromatase deficiency in men: a clinical perspective. Nat Rev Endocrinol (2009) 0.99

Effects of teriparatide treatment and discontinuation in postmenopausal women and eugonadal men with osteoporosis. J Clin Endocrinol Metab (2009) 0.99

Testosterone for the aging male; current evidence and recommended practice. Clin Interv Aging (2008) 0.98

Role of sex steroids in the regulation of bone morphology in men. The MINOS study. Osteoporos Int (2004) 0.96

The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. J Clin Endocrinol Metab (2010) 0.96

Influence of age and sex steroids on bone density and geometry in middle-aged and elderly European men. Osteoporos Int (2010) 0.94

Bone mineral density at the hip in Norwegian women and men--prevalence of osteoporosis depends on chosen references: the Tromsø Study. Eur J Epidemiol (2009) 0.93

Testicular function and bone metabolism--beyond testosterone. Nat Rev Endocrinol (2013) 0.93

Endogenous sex steroids, weight change and rates of hip bone loss in older men: the MrOS study. Osteoporos Int (2006) 0.92

Male osteoporosis. Endocrinol Metab Clin North Am (2012) 0.92

Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men. Osteoporos Int (2005) 0.91

Men, bone and estrogen: unresolved issues. Osteoporos Int (2003) 0.89

Aromatase inhibitors in men: effects and therapeutic options. Reprod Biol Endocrinol (2011) 0.88

Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strength. J Clin Endocrinol Metab (2008) 0.88

Sex steroids and bone health status in men. Int J Endocrinol (2012) 0.87

Androgens and estrogens in skeletal sexual dimorphism. Asian J Androl (2014) 0.85

Serum estradiol levels are inversely associated with cortical porosity in older men. J Clin Endocrinol Metab (2014) 0.85

Osteoporosis in men. Nat Rev Endocrinol (2013) 0.85

Increasing adiposity is associated with higher adipokine levels and lower bone mineral density in obese older adults. J Clin Endocrinol Metab (2014) 0.85

The relation of the XbaI and PvuII polymorphisms of the estrogen receptor gene and the CAG repeat polymorphism of the androgen receptor gene to peak bone mass and bone turnover rate among young healthy men. Osteoporos Int (2005) 0.85

Single, escalating dose pharmacokinetics, safety and food effects of a new oral androgen dimethandrolone undecanoate in man: a prototype oral male hormonal contraceptive. Andrology (2014) 0.83

The association of concurrent vitamin D and sex hormone deficiency with bone loss and fracture risk in older men: the osteoporotic fractures in men (MrOS) study. J Bone Miner Res (2012) 0.83

Testosterone increases bone mineral density in female-to-male transsexuals: a case series of 15 subjects. Clin Endocrinol (Oxf) (2004) 0.83

The role of activation functions 1 and 2 of estrogen receptor-α for the effects of estradiol and selective estrogen receptor modulators in male mice. J Bone Miner Res (2013) 0.82

Regulation of male fertility by the bone-derived hormone osteocalcin. Mol Cell Endocrinol (2013) 0.82

Sex steroids and bone health in older Chinese men. Osteoporos Int (2011) 0.82

The androgen-deficient aging male: current treatment options. Rev Urol (2003) 0.82

Weak Epistasis Generally Stabilizes Phenotypes in a Mouse Intercross. PLoS Genet (2016) 0.82

Estrogen regulates T helper 17 phenotype and localization in experimental autoimmune arthritis. Arthritis Res Ther (2015) 0.81

Gonadal sex steroid status and bone health in middle-aged and elderly European men. Osteoporos Int (2009) 0.81

Estrogens and Androgens in Skeletal Physiology and Pathophysiology. Physiol Rev (2017) 0.81

Male Osteoporosis in the Elderly. Int J Endocrinol (2015) 0.81

Relationship of sex steroid hormones with body size and with body composition measured by dual-energy X-ray absorptiometry in US men. Cancer Causes Control (2012) 0.80

The endocrine role of estrogens on human male skeleton. Int J Endocrinol (2015) 0.80

Comparison of plasma endothelin levels between osteoporotic, osteopenic and normal subjects. BMC Musculoskelet Disord (2005) 0.80

Role of parathyroid hormone in mediating age-related changes in bone resorption in men. Osteoporos Int (2003) 0.80

Osteoporosis: "A risk factor for periodontitis". J Indian Soc Periodontol (2009) 0.80

Testosterone and Adipokines are Determinants of Physical Performance, Strength, and Aerobic Fitness in Frail, Obese, Older Adults. Int J Endocrinol (2014) 0.80

Rates of bone loss in young adult males. Int J Clin Rheumtol (2010) 0.79

Rural vs. non-rural differences and longitudinal bone changes by DXA and pQCT in men aged 20-66 years: A population-based study. Bone (2015) 0.79

Androgen therapy in the aging male. World J Urol (2003) 0.79

The effect of estrogen on bone requires ERα in nonhematopoietic cells but is enhanced by ERα in hematopoietic cells. Am J Physiol Endocrinol Metab (2014) 0.79

Sex steroids and bone health in men. Bonekey Rep (2012) 0.79

BMI and BMD: The Potential Interplay between Obesity and Bone Fragility. Int J Environ Res Public Health (2016) 0.79

Case scenarios in androgen deficiency. Rev Urol (2003) 0.79

A prospective, multicenter, open-label trial of zoledronic acid in patients with hormone refractory prostate cancer. Yonsei Med J (2007) 0.78

Quantification of the relative contribution of estrogen to bone mineral density in men and women. BMC Musculoskelet Disord (2013) 0.78

Age-related changes in sex steroid levels influence bone mineral density in healthy Indian men. Osteoporos Int (2008) 0.78

Osteocalcin increase after bariatric surgery predicts androgen recovery in hypogonadal obese males. Int J Obes (Lond) (2013) 0.78

Rates of and risk factors for trabecular and cortical BMD loss in middle-aged and elderly African-ancestry men. J Bone Miner Res (2015) 0.77

Aromatase activity and bone loss in men. J Osteoporos (2011) 0.77

How pregnancy can affect autoimmune diseases progression? Clin Mol Allergy (2016) 0.77

Association between estrogen receptor-β dinucleotide repeat polymorphism and incidence of femoral fracture. J Bone Miner Metab (2012) 0.77

Relative contributions of multiple determinants to bone mineral density in men. Osteoporos Int (2009) 0.77

Serum uric acid levels and mortality in the Japanese population: the Yamagata (Takahata) study. Clin Exp Nephrol (2016) 0.77

The osteoporotic male: overlooked and undermanaged? Clin Interv Aging (2007) 0.76

Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8. Support Care Cancer (2009) 0.76

Recent topics related to testosterone deficiency syndrome in Japan. Asian J Androl (2011) 0.76

Capacity of endogenous sex steroids to predict bone loss in Japanese men: 10-year follow-up of the Taiji Cohort Study. J Bone Miner Metab (2010) 0.75

Sex steroids, periodontal health, and tooth loss in older men. J Dent Res (2009) 0.75

Aging, lifestyle factors, hormones and bone health in Singaporean men. Bone Rep (2016) 0.75

Bone turnover predicts change in volumetric bone density and bone geometry at the radius in men. Osteoporos Int (2016) 0.75

Pathogenesis of Osteoporosis. Transl Endocrinol Metab (2010) 0.75

Aging and estradiol effects on gene expression in the medial preoptic area, bed nucleus of the stria terminalis, and posterodorsal medial amygdala of male rats. Mol Cell Endocrinol (2016) 0.75

Proximity of the mandibular molar root apex from the buccal bone surface: a cone-beam computed tomographic study. Restor Dent Endod (2016) 0.75

The osteoporosis revolution marches on. J Orthop Sci (2007) 0.75

Searching for additional endocrine functions of the skeleton: genetic approaches and implications for therapeutics. Expert Rev Endocrinol Metab (2015) 0.75

Articles by these authors

Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet (2003) 11.91

The diagnosis of osteoporosis. J Bone Miner Res (1994) 10.90

Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43

Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med (1994) 9.25

Hip fractures in the elderly: a world-wide projection. Osteoporos Int (1992) 9.08

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

Involutional osteoporosis. N Engl J Med (1986) 8.20

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62

Psychotropic drug use and the risk of hip fracture. N Engl J Med (1987) 7.53

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44

The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76

Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med (1990) 5.49

Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) (1982) 5.29

A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis (1992) 5.22

Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA (1996) 5.17

A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92

Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84

Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res (1992) 4.75

Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 4.74

Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology (2007) 4.28

Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28

A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res (1998) 4.24

Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18

Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16

Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke (1996) 4.13

Potential effect of authorization bias on medical record research. Mayo Clin Proc (1999) 4.01

Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90

The prevention and treatment of osteoporosis. N Engl J Med (1992) 3.90

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77

Lymphoid neogenesis in rheumatoid synovitis. J Immunol (2001) 3.63

The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol (2000) 3.62

Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest (1981) 3.60

Carpal tunnel syndrome in Rochester, Minnesota, 1961 to 1980. Neurology (1988) 3.40

Thoracic aortic aneurysms: a population-based study. Surgery (1982) 3.36

Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34

Epidemiology of vertebral fractures in women. Am J Epidemiol (1989) 3.27

Perturbation of the T-cell repertoire in patients with unstable angina. Circulation (1999) 3.20

The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol (1980) 3.19

Verifying the stroke-free phenotype by structured telephone interview. Stroke (2000) 3.15

The Autonomic Symptom Profile: a new instrument to assess autonomic symptoms. Neurology (1999) 3.09

Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08

Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain (1994) 3.07

Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am Rev Respir Dis (1979) 3.06

T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 3.06

Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int (2011) 3.04

Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood (1993) 2.98

Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum (1999) 2.98

Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med (1999) 2.98

Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest (2000) 2.94

Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation (1989) 2.94

Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Relat Res (1981) 2.93

Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92

Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89

Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85

Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int (1999) 2.83

Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood (1992) 2.81

Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc (1999) 2.80

Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med (1986) 2.80

Epidemiologic features of humeral fractures. Clin Orthop Relat Res (1982) 2.79

Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int (1979) 2.79

Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. Stroke (2000) 2.78

Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol (2001) 2.78

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77

Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75

Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int (2008) 2.74

Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int (2008) 2.72

Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation (1999) 2.71

Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol (2000) 2.68

Intercessory prayer and cardiovascular disease progression in a coronary care unit population: a randomized controlled trial. Mayo Clin Proc (2001) 2.61

Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res (1993) 2.59

Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke (1999) 2.56

Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54

The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum (1999) 2.50

Long-term survival of a cohort of community residents with asthma. N Engl J Med (1994) 2.47

Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis (2007) 2.46

Emotional responses of athletes to injury. Mayo Clin Proc (1990) 2.43

Accuracy of the death certificate in a population-based study of asthmatic patients. JAMA (1993) 2.42

Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy: with results of surgery and hemodynamics of cerebral ischemia. Mayo Clin Proc (1981) 2.41

Secular trends in the incidence of hip fractures. Calcif Tissue Int (1987) 2.40

Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res (1990) 2.39